SIX Swiss Exchange · Healthcare
Invest in Idorsia stock from India
Indian and foreign residents can buy Idorsia (IDIA) shares directly through Paasa.
By Paasa · Updated
Idorsia at a glance
- Price
- CHF 4.63+CHF 0.20 (4.42%)
- Market cap
- CHF 1.22B
- Day range
- CHF 4.40 – CHF 4.63
- P/E
- -3.54
- Dividend yield
- None
- Volume
- 256.05K
- 1 month
- -13.22%
- 6 months
- +50.94%
- YTD
- +8.78%
- 1 year
- +21.31%
- 5 years
- -79.48%
Idorsia statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 221.0M | CHF 112.5M | CHF 152.4M | CHF 97.1M | CHF 35.3M |
| Gross profit | CHF 182.2M | −CHF 67.1M | CHF 145.2M | CHF 90.8M | CHF 17.3M |
| Operating income | −CHF 131.0M | −CHF 232.0M | −CHF 255.1M | −CHF 803.0M | −CHF 613.0M |
| Net income | −CHF 112.0M | −CHF 263.8M | −CHF 297.9M | −CHF 827.9M | −CHF 634.6M |
| Earnings per share | −CHF 0.52 | −CHF 1.45 | −CHF 1.67 | −CHF 4.67 | −CHF 3.77 |
| EBITDA | −CHF 45.5M | −CHF 319.5M | −CHF 254.6M | −CHF 783.1M | −CHF 588.8M |
| Total assets | CHF 465.9M | CHF 505.9M | CHF 500.0M | CHF 904.2M | CHF 1.5B |
| Total debt | CHF 1.3B | CHF 1.3B | CHF 1.2B | CHF 1.2B | CHF 1.2B |
| Cash and short-term investments | CHF 87.2M | CHF 124.4M | CHF 157.8M | CHF 476.3M | CHF 1.0B |
| Shareholders' equity | −CHF 1.1B | −CHF 1.2B | −CHF 968.7M | −CHF 661.0M | CHF 104.2M |
| Operating cash flow | −CHF 153.2M | −CHF 370.2M | −CHF 629.3M | −CHF 859.1M | −CHF 589.9M |
| Free cash flow | −CHF 167.0M | −CHF 373.2M | −CHF 638.7M | −CHF 886.2M | −CHF 620.8M |
| Capital expenditure | −CHF 13.8M | −CHF 3.0M | −CHF 9.4M | −CHF 27.1M | −CHF 30.9M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| PolyPeptide | PPGN.SW | CHF 44.10 | CHF 1.46B |
| Medartis | MED.SW | CHF 84.30 | CHF 1.05B |
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Idorsia from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search IDIA and buy
Find Idorsia by name or by its ticker, IDIA, and place your order.
Why invest in Idorsia from India
What Idorsia does
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. Idorsia operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Idorsia stock from India?
Yes. Indian residents and NRIs can buy Idorsia (IDIA) shares directly through Paasa. Idorsia is listed on the SIX Swiss Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Idorsia shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.